Preconceptional exposure to oral contraceptive pills and the risk of wheeze, asthma and rhinitis in children

Allergology International

Volumn 65, Issue 3, 2016, Pages 327-331

  Yamamoto Hanada, Kiwako ^a,d   Futamura, Masaki ^a,c   Yang, Limin ^a   Shoda, Tetsuo ^a   Narita, Masami ^a   Kobayashi, Fumio ^d   Saito, Hirohisa ^b   Ohya, Yukihiro ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^d AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma; Birth cohort; Oral contraceptives; Rhinitis; Wheeze

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; ASTHMA; BODY MASS; CHILDHOOD DISEASE; ECZEMA; EDUCATIONAL STATUS; FEMALE; HISTORY; HUMAN; JAPAN; LIVE BIRTH; MATERNAL AGE; ORAL CONTRACEPTIVE USE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RHINITIS; WHEEZING; ADVERSE EFFECTS; COHORT ANALYSIS; HEALTH SURVEY; INFANT; MALE; MATERNAL EXPOSURE; NEWBORN; ODDS RATIO; OUTCOME ASSESSMENT; PREGNANCY; PRENATAL EXPOSURE; PRESCHOOL CHILD; PREVALENCE; RESPIRATORY SOUNDS; RISK;

ASTHMA; CHILD, PRESCHOOL; COHORT STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MATERNAL EXPOSURE; ODDS RATIO; PATIENT OUTCOME ASSESSMENT; POPULATION SURVEILLANCE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; RESPIRATORY SOUNDS; RHINITIS; RISK;

EID: 84962079671     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.1016/j.alit.2016.02.012     Document Type: Article

References (20)

1. 1 Asher, M.I., Montefort, S., Bjorksten, B., Lai, C.K., Strachan, D.P., Weiland, S.K., et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 368 (2006), 733–743.
2. 2 Wong, G.W., Leung, T.F., Ko, F.W., Changing prevalence of allergic diseases in the Asia-pacific region. Allergy Asthma Immunol Res 5 (2013), 251–257.
3. 3 Futamura, M., Ohya, Y., Akashi, M., Adachi, Y., Odajima, H., Akiyama, K., et al. Age-related prevalence of allergic diseases in Tokyo schoolchildren. Allergol Int 60 (2011), 509–515.
4. 4 Kauffmann, F., Demenais, F., Gene-environment interactions in asthma and allergic diseases: challenges and perspectives. J Allergy Clin Immunol 130 (2012), 1229–1240 quiz 41–2.
5. 5 Swanson, J.M., Entringer, S., Buss, C., Wadhwa, P.D., Developmental origins of health and disease: environmental exposures. Semin Reprod Med 27 (2009), 391–402.
6. 6 Gillman, M.W., Barker, D., Bier, D., Cagampang, F., Challis, J., Fall, C., et al. Meeting report on the 3rd International Congress on Developmental Origins of Health and Disease (DOHaD). Pediatr Res 61:5 Pt 1 (2007), 625–629.
7. 7 Brooks, K., Samms-Vaughan, M., Karmaus, W., Are oral contraceptive use and pregnancy complications risk factors for atopic disorders among offspring?. Pediatr Allergy Immunol 15 (2004), 487–496.
8. 8 Osman, M.F., Black, C., Jick, S., Hannaford, P., Previous maternal oral contraception and the risk among subsequent offspring of asthma diagnosis in early childhood. Paediatr Perinat Epidemiol 23 (2009), 567–573.
9. 9 Hancock, D.B., Haberg, S.E., Furu, K., Whitworth, K.W., Nafstad, P., Nystad, W., et al. Oral contraceptive pill use before pregnancy and respiratory outcomes in early childhood. Pediatr Allergy Immunol 22 (2011), 528–536.
10. 10 Jwa, S.C., Fujiwara, T., Hata, A., Arata, N., Sago, H., Ohya, Y., BMI mediates the association between low educational level and higher blood pressure during pregnancy in Japan. BMC Public Health, 13, 2013, 389.
11. 11 Jwa, S.C., Arata, N., Sakamoto, N., Watanabe, N., Aoki, H., Kurauchi-Mito, A., et al. Prediction of pregnancy-induced hypertension by a shift of blood pressure class according to the JSH 2009 guidelines. Hypertens Res 34 (2011), 1203–1208.
12. 12 Frye, C., Mueller, J.E., Niedermeier, K., Wjst, M., Heinrich, J., Maternal oral contraceptive use and atopic diseases in the offspring. Allergy 58 (2003), 229–232.
13. 13 Wei, J., Gerlich, J., Genuneit, J., Nowak, D., Vogelberg, C., von Mutius, E., et al. Hormonal factors and incident asthma and allergic rhinitis during puberty in girls. Ann Allergy Asthma Immunol 115 (2015), 21–27 e2.
14. 14 Troisi, R.J., Speizer, F.E., Willett, W.C., Trichopoulos, D., Rosner, B., Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study. Am J Respir Crit Care Med 152 (1995), 1183–1188.
15. 15 Matsumoto, Y., Yamabe, S., Sugishima, T., Geronazzo, D., Perception of oral contraceptives among women of reproductive age in Japan: a comparison with the USA and France. J Obstet Gynaecol Res 37 (2011), 887–892.
16. 16 Beasley, R., Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351 (1998), 1225–1232.
17. 17 United Nations DoEaSA, Population Division. World Contraceptive Use 2011. Available from: http://www.un.org/esa/population/publications/contraceptive2011/wallchart_wcu2011.xls.
18. 18 Guthikonda, K., Zhang, H., Nolan, V.G., Soto-Ramirez, N., Ziyab, A.H., Ewart, S., et al. Oral contraceptives modify the effect of GATA3 polymorphisms on the risk of asthma at the age of 18 years via DNA methylation. Clin Epigenetics, 6, 2014, 17.
19. 19 Prescott, S.L., Disease prevention in the age of convergence – the need for a wider, long ranging and collaborative vision. Allergol Int 63 (2014), 11–20.
20. 20 Perzanowski, M.S., Miller, R.L., Tang, D., Ali, D., Garfinkel, R.S., Chew, G.L., et al. Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort. Thorax 65 (2010), 118–123.